Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors
Clinical trial NCT03112694 · COMPLETED
Trial details
- NCT number
- NCT03112694
- Sponsor
- Ipsen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-04-04
- Primary completion
- 2017-11-02
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.